Prestige Consumer Healthcare Inc.
PBHPharmaceutical Preparations · SIC 2834 · CIK 0001295947
Revenue FY2026
$1.09B
Net Income
$0.19B
EPS (Basic)
$3.93
Net Margin
17.5%
ROE
10.1%
Total Equity
$1.89B
Shares Out
47M
Prestige Consumer Healthcare Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2010–FY2026; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 6 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Ariel Investments
John Rogers
$230.1M
1.8%
+13.9%
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
$110.2M
0.4%
NEW
Olstein Capital Management
Robert Olstein
$1.2M
0.2%
—
Maverick Capital
Lee Ainslie
$2.4M
0.0%
NEW
Royce & Associates
Royce & Associates
$1.8M
0.0%
(75.5%)
Bridgewater Associates
Bridgewater Associates
$2.2M
0.0%
NEW
Insider Transactions
Reading stored insider transactions…